In the present study, we summarize the data of clinical characteristics of 114 cases of lung adenocarcinoma patients, explore the relationship between VEGFC and PD‐L1 expression in patients with resected lung adenocarcinoma, and search for their predictive value in future immunotherapy for patients with lung adenocarcinoma. This evidence concerns the gene VEGFC and lung adenocarcinoma.